Pulse Biosciences PE Ratio 2016-2024 | PLSE
Current and historical p/e ratio for Pulse Biosciences (PLSE) from 2016 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Pulse Biosciences PE ratio as of October 11, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Pulse Biosciences PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-10-10 | 15.60 | 0.00 | |
| 2024-06-30 | 11.19 | $-0.59 | 0.00 |
| 2024-03-31 | 8.71 | $-0.81 | 0.00 |
| 2023-12-31 | 12.24 | $-0.89 | 0.00 |
| 2023-09-30 | 4.03 | $-0.92 | 0.00 |
| 2023-06-30 | 7.19 | $-1.22 | 0.00 |
| 2023-03-31 | 3.36 | $-1.44 | 0.00 |
| 2022-12-31 | 2.77 | $-1.76 | 0.00 |
| 2022-09-30 | 2.30 | $-2.03 | 0.00 |
| 2022-06-30 | 1.53 | $-2.02 | 0.00 |
| 2022-03-31 | 4.86 | $-2.16 | 0.00 |
| 2021-12-31 | 14.81 | $-2.29 | 0.00 |
| 2021-09-30 | 21.60 | $-2.31 | 0.00 |
| 2021-06-30 | 16.40 | $-2.34 | 0.00 |
| 2021-03-31 | 23.68 | $-2.29 | 0.00 |
| 2020-12-31 | 23.86 | $-2.15 | 0.00 |
| 2020-09-30 | 11.79 | $-2.27 | 0.00 |
| 2020-06-30 | 10.46 | $-2.33 | 0.00 |
| 2020-03-31 | 7.16 | $-2.35 | 0.00 |
| 2019-12-31 | 13.41 | $-2.27 | 0.00 |
| 2019-09-30 | 15.44 | $-2.12 | 0.00 |
| 2019-06-30 | 13.20 | $-2.19 | 0.00 |
| 2019-03-31 | 17.59 | $-2.18 | 0.00 |
| 2018-12-31 | 11.46 | $-2.20 | 0.00 |
| 2018-09-30 | 14.19 | $-2.22 | 0.00 |
| 2018-06-30 | 15.14 | $-2.10 | 0.00 |
| 2018-03-31 | 13.53 | $-1.99 | 0.00 |
| 2017-12-31 | 23.60 | $-1.71 | 0.00 |
| 2017-09-30 | 18.61 | $-1.39 | 0.00 |
| 2017-06-30 | 34.53 | $-1.08 | 0.00 |
| 2017-03-31 | 20.41 | $-0.88 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.047B | $0.001B |
| Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications which include human oncology, dermatology, aesthetics and other minimally invasive applications. Pulse Biosciences, Inc. is based in Burlingame, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.021B | 27.33 |
| Intuitive Surgical (ISRG) | United States | $172.269B | 97.54 |
| Alcon (ALC) | Switzerland | $47.692B | 33.57 |
| IQVIA Holdings (IQV) | United States | $41.794B | 23.68 |
| Edwards Lifesciences (EW) | United States | $41.042B | 26.31 |
| IDEXX Laboratories (IDXX) | United States | $39.200B | 47.16 |
| DexCom (DXCM) | United States | $27.734B | 39.55 |
| STERIS (STE) | Ireland | $22.376B | 26.11 |
| SONOVA HOLDING (SONVY) | Switzerland | $22.049B | 0.00 |
| Waters (WAT) | United States | $21.250B | 31.68 |
| Hologic (HOLX) | United States | $18.538B | 20.15 |
| Sysmex ADR (SSMXY) | Japan | $12.254B | 38.43 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.502B | 12.89 |
| Teleflex (TFX) | United States | $11.121B | 17.29 |
| Globus Medical (GMED) | United States | $9.556B | 26.73 |
| Penumbra (PEN) | United States | $7.893B | 81.93 |
| Masimo (MASI) | United States | $7.481B | 40.06 |
| Glaukos (GKOS) | United States | $6.973B | 0.00 |
| TransMedics (TMDX) | United States | $4.510B | 193.13 |
| Integer Holdings (ITGR) | United States | $4.334B | 25.34 |
| PROCEPT BioRobotics (PRCT) | United States | $3.724B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.852B | 16.73 |
| Veracyte (VCYT) | United States | $2.613B | 162.00 |
| Elekta AB (EKTAY) | Sweden | $2.595B | 21.14 |
| Inari Medical (NARI) | United States | $2.436B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.427B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.246B | 13.98 |
| RxSight (RXST) | United States | $1.857B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.492B | 6.80 |
| Artivion (AORT) | United States | $1.086B | 99.69 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.037B | 18.50 |
| OPKO Health (OPK) | United States | $1.018B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.723B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.683B | 17.24 |
| AxoGen (AXGN) | United States | $0.645B | 0.00 |
| IRadimed (IRMD) | United States | $0.639B | 34.53 |
| OrthoPediatrics (KIDS) | United States | $0.596B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.595B | 0.00 |
| SiBone (SIBN) | United States | $0.547B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.540B | 0.00 |
| Paragon 28 (FNA) | United States | $0.478B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.336B | 10.26 |
| Treace Medical Concepts (TMCI) | United States | $0.327B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.320B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.289B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.260B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.231B | 0.00 |
| Inogen (INGN) | United States | $0.213B | 0.00 |
| NeuroPace (NPCE) | United States | $0.193B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.192B | 13.46 |
| Accuray (ARAY) | United States | $0.184B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.181B | 0.00 |
| Nevro (NVRO) | United States | $0.180B | 0.00 |
| CVRx (CVRX) | United States | $0.163B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.153B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.125B | 0.00 |
| 908 Devices (MASS) | United States | $0.120B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.109B | 16.15 |
| EDAP TMS S.A (EDAP) | France | $0.097B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.080B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| InspireMD (NSPR) | Israel | $0.065B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.063B | 0.00 |
| LENSAR (LNSR) | United States | $0.056B | 0.00 |
| Envoy Medical (COCH) | United States | $0.052B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.043B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.042B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.038B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.038B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Neuronetics (STIM) | United States | $0.028B | 0.00 |
| Precision Optics (POCI) | United States | $0.027B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.026B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.025B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.022B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |